Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Campone, Mario"'
Autor:
Johnston SRD; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: stephen.johnston@rmh.nhs.uk., Toi M; Kyoto University, Kyoto, Japan., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA., Rastogi P; University of Pittsburgh/UPMC, NSABP Foundation, Pittsburgh, PA, USA., Campone M; Institute de Cancérologie de l'Ouest, Centre Rene Cauducheau, Saint-Herblain, Nantes, France., Neven P; Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Leuven, Belgium., Huang CS; National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan., Huober J; Cantonal Hospital St Gallen, Breast Centre St Gallen, Switzerland., Jaliffe GG; Grupo Medico Camino SC, Mexico City, Mexico., Cicin I; Trakya University Faculty of Medicine, Edirne, Turkey., Tolaney SM; Dana-Farber Cancer Institute, Boston, MA, USA., Goetz MP; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Rugo HS; University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Testa L; Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, Brazil., Del Mastro L; IRCSS Ospedale Policlinico San Martino, UO Breast Unit, Genoa, Italy; Università di Genova, Department of Internal Medicine and Medical Specialties (DIM), Genoa, Italy., Shimizu C; National Centre for Global Health and Medicine, Tokyo, Japan., Wei R; Eli Lilly and Company, Indianapolis, IN, USA., Shahir A; Loxo@Lilly, Indianapolis, IN, USA., Munoz M; Loxo@Lilly, Indianapolis, IN, USA., San Antonio B; Loxo@Lilly, Indianapolis, IN, USA., André V; Eli Lilly and Company, Indianapolis, IN, USA., Harbeck N; Breast Centre, Department of Gynaecology and Obstetrics, Comprehensive Cancer Centre München, LMU University Hospital, Munich, Germany., Martin M; Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Jan; Vol. 24 (1), pp. 77-90. Date of Electronic Publication: 2022 Dec 06.
Autor:
Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: patrick_wen@dfci.harvard.edu., Stein A; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., van den Bent M; Brain Tumor Center and Department of Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands., De Greve J; University Hospital Vrije Universiteit Brussel, Brussels, Belgium., Wick A; Department of Neurology, University of Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany., de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, Netherlands., von Bubnoff N; University Medical Center Freiburg, Freiburg, Germany; Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Lübeck, Germany., van Linde ME; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands., Lai A; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Prager GW; Department of Medicine I, AKH Wien, Medical University of Vienna, Vienna, Austria., Campone M; Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Fasolo A; Department of Medical Oncology, Ospedale San Raffaele IRCCS, Milan, Italy., Lopez-Martin JA; 12 de Octubre University Hospital & Research Institute, Madrid, Spain., Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea., Mason WP; University Health Network, University of Toronto, Toronto, ON, Canada., Hofheinz RD; University Hospital of Mannheim, Mannheim, Germany., Blay JY; Center Leon Berard & University Claude Bernard Lyon I, Lyon, France., Cho DC; New York Medical College, Valhalla, New York, NY, USA., Gazzah A; Gustave Roussy Cancer Institute, Villejuif, France., Pouessel D; Department of Medical Oncology & Clinical Research Unit, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Yachnin J; Karolinska University Hospital, Theme Cancer, Center for Clinical Cancer Studies, Solna, Sweden., Boran A; Global Drug Development, Oncology Development Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Burgess P; Global Drug Development, Oncology Development Unit, Novartis Pharma AG, Basel, Switzerland., Ilankumaran P; Global Drug Development, Oncology Development Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Gasal E; Global Drug Development, Oncology Development Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Jan; Vol. 23 (1), pp. 53-64. Date of Electronic Publication: 2021 Nov 24.
Autor:
Diéras V; Institut Curie, Paris, France; Breast Oncology, Centre Eugène Marquis, Rennes, France. Electronic address: v.dieras@rennes.unicancer.fr., Han HS; Moffitt Cancer Center, Tampa, FL, USA., Kaufman B; Tel-Aviv University, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Friedlander M; Prince of Wales Clinical School UNSW and Prince of Wales Hospital, Sydney, NSW, Australia., Ayoub JP; Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Puhalla SL; UPMC Cancer Centers, Pittsburgh, PA, USA., Bondarenko I; Dnipropetrovsk Medical Academy, City Clinical Hospital Number 4, Dnipro, Ukraine., Campone M; Institut de Cancérologie de l'Ouest Saint-Herblain, France., Jakobsen EH; Vejle Hospital/Lillebaelt Hospital, Vejle, Denmark., Jalving M; University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Oprean C; University of Medicine and Pharmacy Timisoara and Oncomed SRL, Timisoara, Romania., Palácová M; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Park YH; Samsung Medical Center, Seoul, South Korea., Shparyk Y; Lviv State Regional Treatment and Diagnostic Oncology Center, Lviv, Ukraine., Yañez E; Universidad de la Frontera, Temuco, Chile., Khandelwal N; AbbVie, North Chicago, IL, USA., Kundu MG; AbbVie, North Chicago, IL, USA., Dudley M; AbbVie, North Chicago, IL, USA., Ratajczak CK; AbbVie, North Chicago, IL, USA., Maag D; AbbVie, North Chicago, IL, USA., Arun BK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Oct; Vol. 21 (10), pp. 1269-1282. Date of Electronic Publication: 2020 Aug 27.
Autor:
Loi S; Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: sherene.loi@petermac.org., Giobbie-Hurder A; IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Gombos A; Institute Jules Bordet, Brussels, Belgium., Bachelot T; Centre Léon Bérard, Lyon, France., Hui R; Westmead Hospital and the University of Sydney, Sydney, NSW, Australia., Curigliano G; University of Milano, Milan, Italy; IEO, European Institute of Oncology IRCCS, Milan, Italy., Campone M; Institut de Cancérologie de l'Ouest, Saint-Herblain, Nantes, France., Biganzoli L; Ospedale di Prato-AUSL Toscana Centro, Prato, Italy., Bonnefoi H; Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France., Jerusalem G; International Breast Cancer Study Group, CHU Liège, Liège University, Liège, Belgium., Bartsch R; Medical University of Vienna, Vienna, Austria., Rabaglio-Poretti M; University Hospital Inselspital, Bern, Switzerland; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland., Kammler R; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; International Breast Cancer Study Group and Central Pathology Office, Bern, Switzerland., Maibach R; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland., Smyth MJ; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Di Leo A; International Breast Cancer Study Group and Ospedale di Prato-AUSL Toscana Centro, Prato, Italy., Colleoni M; International Breast Cancer Study Group and Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Viale G; University of Milano, Milan, Italy; IEO, European Institute of Oncology IRCCS, Milan, Italy; International Breast Cancer Study Group and Central Pathology Office, Bern, Switzerland., Regan MM; IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., André F; Institut Gustave Roussy, Université Paris Sud, INSERM U981, Villejuif, France.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Mar; Vol. 20 (3), pp. 371-382. Date of Electronic Publication: 2019 Feb 11.
Autor:
Hurvitz SA; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: SHurvitz@mednet.ucla.edu., Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain., Symmans WF; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea., Huang CS; National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan., Thompson AM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Harbeck N; Breast Center, University of Munich (LMU), Munich, Germany., Valero V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stroyakovskiy D; Moscow City Oncology Hospital 62, Moscow, Russia., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Campone M; Centre René Gauducheau, St Herblain cedex, France., Boileau JF; McGill University, Sir Mortimer B Davis Jewish General Hospital, Montreal, QC, Canada., Beckmann MW; University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany., Afenjar K; Translational Research in Oncology, Biopark, Paris, France., Fresco R; Translational Research in Oncology, Luis Alberto de Herrera, Montevideo, Uruguay., Helms HJ; F Hoffmann-La Roche, Basel, Switzerland., Xu J; Genentech, San Francisco, CA, USA., Lin YG; Genentech, San Francisco, CA, USA., Sparano J; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA., Slamon D; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Jan; Vol. 19 (1), pp. 115-126. Date of Electronic Publication: 2017 Nov 23.
Autor:
Baselga J; Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: baselgaj@mskcc.org., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea., Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Cortés J; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain., De Laurentiis M; Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy., Jiang Z; Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China., Arteaga CL; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Jonat W; Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany., Clemons M; Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Ito Y; Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Awada A; Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Chia S; Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada., Jagiełło-Gruszfeld A; Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland., Pistilli B; Department of Oncology, Ospedale di Macerata, Macerata, Italy., Tseng LM; Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan., Hurvitz S; Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Masuda N; Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan., Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Vuylsteke P; Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium., Hachemi S; Novartis Pharma SAS, Paris, France., Dharan B; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Di Tomaso E; Syros Pharmaceuticals, Watertown, MA, USA., Urban P; Novartis Pharma AG, Basel, Switzerland., Massacesi C; Novartis Pharma SAS, Paris, France., Campone M; Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2017 Jul; Vol. 18 (7), pp. 904-916. Date of Electronic Publication: 2017 May 30.
Autor:
Bachelot T; Centre Leon Berard, Medical Oncology, Lyon 69008, France. Electronic address: thomas.bachelot@lyon.unicancer.fr., Campone M; Institut de Cancérologie de l'Ouest, Saint-Herblain, Nantes, France., Tredan O; Centre Léon Bérard, Lyon, France.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2016 Jun; Vol. 17 (6), pp. 696-697. Date of Electronic Publication: 2016 May 04.
Autor:
Le Tourneau C; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France; EA7285: Risques cliniques et sécurité en santé des femmes et en santé périnatale, Versailles Saint-Quentin-en Yvelines University, Montigny-le-Bretonneux, France. Electronic address: Christophe.LeTourneau@curie.fr., Delord JP; Department of Medical Oncology, Institut Claudius Régaud, Toulouse, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Gavoille C; Department of Medical Oncology, Centre Alexis Vautrin, Nancy, France., Dubot C; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Isambert N; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Campone M; Department of Medical Oncology, Centre René Gauducheau, Nantes, France., Trédan O; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Massiani MA; Department of Pneumology, Hopital Foch, Suresnes, France., Mauborgne C; Department of Biostatistics, Institut Curie, Paris, France., Armanet S; Clinical Trial Management Unit, Institut Curie, Paris, France., Servant N; Unité INSERM U900, Paris, France., Bièche I; Pharmacogenomics Unit, Institut Curie, Paris, France., Bernard V; NGS Platform, Institut Curie, Paris, France., Gentien D; Translational Research Department, Institut Curie, Paris, France., Jezequel P; Genomic Unit, Centre René Gauducheau, Nantes, France., Attignon V; Genomic Unit, Centre Léon Bérard, Lyon, France., Boyault S; Genomic Unit, Centre Léon Bérard, Lyon, France., Vincent-Salomon A; Department of Biopathology, Institut Curie, Paris, France., Servois V; Department of Radiology, Institut Curie, Paris, France., Sablin MP; Department of Medical Oncoology, Institut Curie, Paris, France., Kamal M; Department of Medical Oncoology, Institut Curie, Paris, France., Paoletti X; Department of Biostatistics, Institut Curie, Paris, France; Unité INSERM U900, Paris, France.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2015 Oct; Vol. 16 (13), pp. 1324-34. Date of Electronic Publication: 2015 Sep 03.
Autor:
André F; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: fabrice.andre@gustaveroussy.fr., Bachelot T; Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France., Commo F; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France., Campone M; Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France., Arnedos M; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France., Dieras V; Department of Medical Oncology, Institut Curie, Paris, France., Lacroix-Triki M; Institut Claudius Regaud, Department of Pathology, Toulouse, France., Lacroix L; Department of Translational Research, Institut Gustave Roussy, Villejuif, France., Cohen P; Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France., Gentien D; Department of Translational Research, Institut Curie, Paris, France., Adélaide J; Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France., Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France., Goncalves A; Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Bonneterre J; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Lefeuvre C; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Jimenez M; Research and Development Unit, UNICANCER, Paris, France., Filleron T; Department of Biostatistics, Institut Claudius Regaud, Toulouse, France., Bonnefoi H; Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2014 Mar; Vol. 15 (3), pp. 267-74. Date of Electronic Publication: 2014 Feb 07.
Autor:
Swain SM; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC 20010, USA. Sandra.M.Swain@MedStar.net, Kim SB, Cortés J, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Knott A, Clark E, Ross G, Benyunes MC, Baselga J
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2013 May; Vol. 14 (6), pp. 461-71. Date of Electronic Publication: 2013 Apr 18.